fda warning letters glp-1 compounding september 26 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications Diabetes advocacy group discourages use

patients describe a quietening of what many in the clinical community now refer to as food noise, the persistent neurological signal that drives overconsumption independent of genuine caloric need

However, caution should be taken while interpreting the augmented T4 levels, as the researchers did not measure fT3 and T4 [103]

While these effects initially made GLP-1 seem a promising candidate for drug development, the earliest clinical studies from 1992 and 1993 revealed that GLP-1s half-life in the body was disappointingly short

Narcolepsy: Low acylcarnitine levels are found in patients with narcolepsy, a sleep disorder that causes daytime drowsiness as well as a sudden loss of muscle tone (cataplexy)